High PSALow volume diseaseRarely, patients with prostate cancer (PC) present with Prostate-Specific Antigen (PSA) scores >20ng/mL but otherwise very low-risk disease. Oncologists debate whether malignancies in these patients behave more comparably to low-risk or high-risk disease. Our objective ...
PSA 意味着长的丙烯酸的高的含量 翻译结果3复制译文编辑译文朗读译文返回顶部 Psa 诊断未通过意味着长的丙烯酸酯的含量高 翻译结果4复制译文编辑译文朗读译文返回顶部 审计科意味着的高含量的长的丙烯酸 翻译结果5复制译文编辑译文朗读译文返回顶部 PSAs手段长的丙烯酸酯的高内容 相关内容 a处理压力的方法 Treating press...
4Department of Oncological Surgery, The Chaim Sheba Medical Center, Tel-Hashomer, Israel; 5Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel While genetic factors clearly play a role in conferring breast cancer risk, the contribution of ATM gene mutations to breast cancer is stil...
Percentage of the ductal component is a significant predictor of PSA recurrence.13 To diagnose ductal adenocarcinoma, one must see large cancer glands lined with tall columnar epithe- lium with stratified nuclei. Several architectural patterns may be seen, including glandular (Figure 3a) (see PIN-...
We used clinical variables to predict prostate cancer detection on re-biopsy among patients diagnosed with high grade prostatic intraepithelial neoplasia (... S Park,K Shinohara,GD Grossfeld,... - 《J Urol》 被引量: 326发表: 2001年 High-grade prostatic intraepithelial neoplasia in patients with ...
1 In 2012, the US Preventive Services Task Force recommended against routine prostate-specific antigen (PSA) screening owing to risk of overdiagnosis of clinically insignificant prostate cancer. Consequently, there has been a decrease in indolent, localized disease, but a concordant increase of ...
Following treatment completion, patients were followed with mostly lab assessment until PSA progression, at which point, treatment was per investigator discretion.” Breast Cancer Overall survival (OS) results from the phase III TROPiCS-02 study of sacituzumab govitecan (SG) vs treatment of ...
initial and repeat biopsies, PSA level range 2.0 to 10.0 ng/mL (n = 335), urine exosome gene expression assay plus SOC (AUC 0.78; 95% CI, 0.72-0.83) vs SOC alone (AUC 0.70; 95% CI, 0.63-0.76) also discriminated ≥GS7 cancer from GS6 and benign disease (P < .001)...
Cancer immunotherapies such as bispecific T-cell engagers have seen limited adoption in prostate cancer (PC), possibly due to differing levels of cancer receptor expression and effector T-cell infiltration between patients and inherent defects in T-cell engager design. Methods CD8+ T-cell infiltration...
Systemic metabolic alterations associated with increased consumption of saturated fat and obesity are linked with increased risk of prostate cancer progression and mortality, but the molecular underpinnings of this association are poorly understood. Here